New York, NYNCT05829109Now EnrollingIRB Ready

Chronic Pouchitis Clinical Trial in New York, NY

Access cutting-edge chronic pouchitis treatment through this early phase 1 clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Maia Kayal

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access chronic pouchitis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic pouchitis treatment provided free

Apply for This New York Location

Check if you qualify for this chronic pouchitis clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Chronic Pouchitis Study in New York

The purpose of this research study is to assess the safety and efficacy of fecal microbiota transplant (FMT) in the treatment of chronic pouchitis.

Sponsor: Maia Kayal

Who Can Participate

Inclusion Criteria

Patients age 18 or greater with UC who have undergone TPC with IPAA and have one of the following chronic pouchitis phenotypes, each defined as:
Chronic antibiotic dependent pouchitis:
The need for continuous antibiotic therapy (\>4 weeks) to maintain clinical remission and a history of at least 2 attempts in the last 24 months to stop antibiotic therapy resulting in pouchitis episodes, OR
Active pouchitis with a modified Pouchitis Disease Activity Index (mPDAI) ≥5 and a history of ≥4 antibiotic therapies in the last 12 months
Chronic antibiotic refractory pouchitis:
Active pouchitis with a modified Pouchitis Disease Activity Index (mPDAI) ≥5 with no response to antibiotics
Crohn's disease like pouch inflammation on biologic or small molecule therapy with persistent symptoms:
Pre-pouch ileal inflammation, strictures, and/or fistulae, AND
Active biologic or small molecule therapy, AND
Persistent symptoms with mPDAI clinical sub-score ≥ 2

Exclusion Criteria

Patients with UC who underwent TPC with IPAA and meet one of the following criteria will be excluded:
Allergy to vancomycin, metronidazole, or ingredients present in the FMT
Women who are breastfeeding
Women who are pregnant
Participants with fever \> 100.4F/38C or other signs of active illness
Active treatment with biologics (infliximab, adalimumab, golimumab, vedolizumab, ustekinumab)
Active treatment with immunomodulators (azathioprine, 6-mercaptopurine, methotrexate), steroids or any investigational drugs
Crohn's disease like pouch inflammation
Active enteric infection
Isolated cuffitis
Clinically significant strictures of the pouch inlet or outlet
Participation in a clinical trial in the preceding 30 days
Any condition that the physician investigators deems unsafe, including other conditions or medications that the investigator determines will put the participant at greater risk from FMT

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT05829109) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Pouchitis Treatment Options in New York, NY

If you're searching for chronic pouchitis treatment options in New York, NY, this clinical trial (NCT05829109) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this early phase 1 clinical trial. You'll receive care from experienced chronic pouchitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic pouchitis clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in New York, NY

See all ulcerative colitis clinical trials recruiting in New York — not just this study.

Browse Ulcerative Colitis Trials in New York →

Browse More Trials by Condition

Ulcerative Colitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY